Form 8-K - Current report:
SEC Accession No. 0001193125-24-259455
Filing Date
2024-11-15
Accepted
2024-11-15 09:54:00
Documents
15
Period of Report
2024-11-14
Items
Item 2.02: Results of Operations and Financial Condition
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d914828d8k.htm   iXBRL 8-K 38985
2 EX-99.1 d914828dex991.htm EX-99.1 76856
3 EX-99.2 d914828dex992.htm EX-99.2 32284
  Complete submission text file 0001193125-24-259455.txt   292240

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA ttoo-20241114.xsd EX-101.SCH 2866
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE ttoo-20241114_lab.xml EX-101.LAB 17236
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ttoo-20241114_pre.xml EX-101.PRE 10823
17 EXTRACTED XBRL INSTANCE DOCUMENT d914828d8k_htm.xml XML 3498
Mailing Address 101 HARTWELL AVENUE LEXINGTON MA 02421
Business Address 101 HARTWELL AVENUE LEXINGTON MA 02421 781-457-1200
T2 Biosystems, Inc. (Filer) CIK: 0001492674 (see all company filings)

EIN.: 204827488 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36571 | Film No.: 241466133
SIC: 3841 Surgical & Medical Instruments & Apparatus
(CF Office: 08 Industrial Applications and Services)